Gold vs US Dollar

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Poseida Therapeutics Inc (PSTX)
Poseida Therapeutics Inc (PSTX) Financials

PSTX Poseida Therapeutics Inc

9.31

-0.02 (-0.21%)

29 Nov 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-196.826	-90.078	-50.06	-39.006	-20.608	-39.452
Return on Equity (%)	115.759	76.495	-230.799	-59.771	-37.231	-84.745
Return on Invested Capital (%)	-737.836	-160.32	-66.105	-59.997	-28.22	-63.875
Operating Margin (%)	N/A	N/A	N/A	-389.321	-43.748	-177.197
Net Profit Margin (%)	N/A	N/A	N/A	-400.07	-49.047	-190.764
Book Value Per Share	-0.641	4.078	4.145	2.41	2.118	1.026
Earnings Per Share	-2.901	-5.258	-2.098	-1.999	-0.745	-1.291
Cash Per Share	1.986	5.334	1.357	3.3	0.947	0.465
Working Capital Per Share	1.281	6.4	4.59	2.728	2.846	1.623
Operating Profit Per Share	N/A	N/A	N/A	0.5	1.518	0.677
EBIT Per Share	-2.914	-5.258	-2.098	-1.999	-0.738	-1.29
EBITDA Per Share	-2.914	-5.258	-2.098	-1.999	-0.738	-1.29
Free Cash Flow Per Share	-2.862	-5.017	-1.866	-2.029	-0.759	-1.317

Liquidity Ratios

Year End 31 December 2023	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	15.31M	16.46M	61.86M	62.52M	85.96M	N/A

Key Stats and Ratios

Year End 31 December 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	85.95M	85.96M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	-355.98	N/A	N/A	N/A	-78.25	N/A
Net Profit Margin (%)	N/A	N/A	-375.587	N/A	N/A	N/A	-86.255	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	909.35M
Price to Earnings Ratio	-7.35
Price to Sales Ratio	14.02
Price to Cash Ratio	20.4
Price to Book Ratio	8.75
Dividend Yield	-

Share Statistics

Shares Outstanding	97.47M
Average Volume (1 week)	6.9M
Average Volume (1 Month)	2.19M
52 Week Change	250.00%
52 Week High	9.42
52 Week Low	1.87

More Ratios Coming Soon!

Poseida Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions